[CHRS] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
06-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -6.60%
YoY- -170.28%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 0 0 0 0 1,395 161 844 -
PBT -43,685 -44,302 -49,069 -58,993 -55,402 -74,822 -75,944 -30.90%
Tax 6,012 2,541 114 2,402 5,938 2,303 428 484.99%
NP -43,638 -44,297 -49,067 -58,989 -55,336 -74,778 -75,921 -30.93%
Tax Rate - - - - - - - -
Total Cost 43,638 44,297 49,067 58,989 56,731 74,939 76,765 -31.44%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 -3,966.74 -46,445.96 -8,995.38 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.68 -0.74 -0.84 -1.09 -1.08 -1.54 -1.71 -46.01%
EPS Diluted -0.68 -0.74 -0.84 -1.09 -1.08 -1.54 -1.71 -46.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.